Drug Profile
Zanamivir controlled release - Ala Wai Pharma
Alternative Names: AWP 09VDB S; Zanamivir gastric resistant - Ala Wai PharmaLatest Information Update: 25 Oct 2021
Price :
$50
*
At a glance
- Originator Ala Wai Pharma
- Class Antivirals; Guanidines; Pyrans; Sialic acids
- Mechanism of Action Neuraminidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 28 Nov 2019 No recent reports of development identified for phase-I development in Influenza-virus-infections(In volunteers) in Australia (PO, Capsule)
- 02 Aug 2017 Chemical structure information added
- 18 Oct 2016 Phase-I clinical trials in Influenza virus infections (In volunteers) in Australia (PO) (ACTRN12616001475437)